de

Registrieren
Investieren birgt Risiken und ist nicht für alle Anleger geeignet.

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Home・Aktien・ACADIA Pharmaceuticals Inc
Search

ACADIA Pharmaceuticals Inc

Geschlossen

Branche Gesundheitswesen

16.09 -0.62

Buy

Kursupdate 6. Sept. 2024, 19:59 UTC

BuySell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

15.97

Max

16.09

Schlüsselkennzahlen

By Trading Economics

Einkommen

17M

33M

Verkäufe

36M

242M

EPS

0.2

Gewinnspanne

13.797

Angestellte

597

EBITDA

12M

33M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+67.58 upside

Dividenden

By Dow Jones

Nächstes Ergebnis

31. Okt. 2024

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

119M

2.7B

Vorheriger Eröffnungskurs

16.71

Vorheriger Schlusskurs

16.09

Nachrichtenstimmung

By Acuity

100%

0%

340 / 365 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

15.69 / 16.33 Unterstützung & Widerstand

ACADIA Pharmaceuticals Inc Chart

Ähnliche Nachrichten

6. Sept. 2024, 22:41 UTC

Market Talk

KinderCare and StandardAero File for IPOs -- Market Talk

DJ

Lesen

6. Sept. 2024, 21:18 UTC

Top News

Hiring Softened This Summer, Teeing Up Fed Rate Cuts -- Update

DJ

Lesen

6. Sept. 2024, 21:05 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- 4th Update

DJ

Lesen

6. Sept. 2024, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Lesen

6. Sept. 2024, 20:39 UTC

Ergebnisse

Update: NIO Stock Caught an Upgrade. Shares Rose. -- Barrons.com

DJ

Lesen

6. Sept. 2024, 20:35 UTC

Top News

Stocks Extend Ugly Week of Losses Amid Economic Uncertainty -- WSJ

DJ

Lesen

6. Sept. 2024, 20:34 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- 3rd Update

DJ

Lesen

6. Sept. 2024, 20:11 UTC

Top News

Stock Indexes Close Lower After Mixed Jobs Report -- WSJ

DJ

Lesen

6. Sept. 2024, 19:51 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- WSJ

DJ

Lesen

6. Sept. 2024, 19:16 UTC

Market Talk

U.S. Natural Gas Futures Hold Gains -- Market Talk

DJ

Lesen

6. Sept. 2024, 19:14 UTC

Market Talk

Oil Futures Extend Losses on Demand Concerns -- Market Talk

DJ

Lesen

6. Sept. 2024, 19:01 UTC

Market Talk

Gold Slips on Prevailing Uncertainty -- Market Talk

DJ

Lesen

6. Sept. 2024, 18:27 UTC

Top News

JPMorgan Plans to Report Customers Who Exploited TikTok 'Glitch' to Authorities -- WSJ

DJ

Lesen

6. Sept. 2024, 18:25 UTC

Market Talk

Broadcom Growth Views Conservative Amid AI Investments -- Market Talk

DJ

Lesen

6. Sept. 2024, 18:15 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- Update

DJ

Lesen

6. Sept. 2024, 18:12 UTC

Top News

Nasdaq Falls 2.5%, Leads Losses After Mixed Jobs Report -- WSJ

DJ

Lesen

6. Sept. 2024, 17:44 UTC

Market Talk

Labor Costs Represent Diminishing Risk To Canada CPI, CIBC's Shenfeld Says -- Market Talk

DJ

Lesen

6. Sept. 2024, 17:30 UTC

Market Talk

U.S Oil Rig Count Unchanged at 483 -- Market Talk

DJ

Lesen

6. Sept. 2024, 17:30 UTC

Top News

Boeing's Starliner Is Returning to Earth Without Its Crew -- WSJ

DJ

Lesen

6. Sept. 2024, 17:27 UTC

Top News

Hiring Softened This Summer, Teeing Up Fed Rate Cuts -- WSJ

DJ

Lesen

6. Sept. 2024, 17:00 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lesen

6. Sept. 2024, 17:00 UTC

Market Talk

Mexican Inflation Seen Easing in August -- Market Talk

DJ

Lesen

6. Sept. 2024, 16:36 UTC

Market Talk

Oil Futures Fall as U.S. Jobs Report Sinks In -- Market Talk

DJ

Lesen

6. Sept. 2024, 16:35 UTC

Ergebnisse
Heiße Aktien

Stocks to Watch Friday: Broadcom, Nvidia, UiPath, Smith & Wesson -- WSJ

DJ

Lesen

6. Sept. 2024, 16:33 UTC

Akquisitionen, Fusionen, Übernahmen

Salesforce Stock Is on Pace for Longest Losing Streak Since 2008. An Acquisition Isn't Helping. -- Barrons.com

DJ

Lesen

6. Sept. 2024, 16:20 UTC

Market Talk
Ergebnisse

Tech, Media & Telecom Roundup: Market Talk

DJ

Lesen

6. Sept. 2024, 16:20 UTC

Ergebnisse

Oracle Profit, Revenue Set to Rise in 1Q -- Earnings Preview

DJ

Lesen

6. Sept. 2024, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Lesen

6. Sept. 2024, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Lesen

6. Sept. 2024, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

DJ

Lesen

Peer-Vergleich

Kursveränderung

ACADIA Pharmaceuticals Inc Prognose

Kursziel

By TipRanks

67.58% Vorteil

12-Monats-Prognose

Durchschnitt 26.93 USD  67.58%

Hoch 39 USD

Tief 17 USD

Basierend auf 18 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für ACADIA Pharmaceuticals Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

18 ratings

13

Buy

5

Halten

0

Sell

Basierend auf 18 Analysten, die in den letzten 3 Monaten Aktienbewertungen für ACADIA Pharmaceuticals Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

15.69 / 16.33Unterstützung & Widerstand

Kurzfristig

Bearish Evidence

Recent bearish events outweigh bullish events.

Mittelfristig

Bearish Evidence

Recent bearish events outweigh bullish events.

Langfristig

No Evidence

There are no events.

Stimmung

By Acuity

340 / 365 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

EBITDA

Betriebsergebnis

$

Über ACADIA Pharmaceuticals Inc

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system disorders. The Company's product pipeline includes NUPLAZID (pimavanser), Trofinetide, ACP-044 and ACP-319. NUPLAZID (pimavanserin) is used for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis (PDP). NUPLAZID is a selective serotonin inverse agonist/antagonist, preferentially targeting 5-HT2A receptors with no appreciable affinity for dopaminergic, histaminergic, or muscarinic receptors. Trofinetide is a synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome. ACP-044, is an orally administered, non-opioid analgesic being evaluated for the treatment of pain. ACP-319 is a positive allosteric modulator of the muscarinic receptor targeting M1 (M1 PAM).

Andere Aktien aus dem Sektor

LLY

Eli Lilly and Co.

902.74

↓-0.9%

UNH

UnitedHealth Group Inc

596.8

↑ +0.31%

NVO

Novo Nordisk A-S

131.05

↑ +0.18%

JNJ

Johnson and Johnson

164.37

↓-0.29%

ABBV

AbbVie Inc

193.18

↑ +0.34%